Private Capital Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

Private Capital Group’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1K	Hold	45	–	–	﹤0.01%	1724
2022 Q1	$1K	Hold	45	–	–	﹤0.01%	1950
2021 Q4	$1K	Hold	45	–	–	﹤0.01%	1946
2021 Q3	$1K	Hold	45	–	–	﹤0.01%	2006
2021 Q2	$1K	Hold	45	–	–	﹤0.01%	1975
2021 Q1	$1K	Hold	45	–	–	﹤0.01%	1883
2020 Q4	$1K	Hold	45	–	–	﹤0.01%	1908
2020 Q3	$0	Hold	45	–	–	﹤0.01%	2046
2020 Q2	$0	Hold	45	–	–	﹤0.01%	2069
2020 Q1	$0	Hold	45	–	–	﹤0.01%	2045
2019 Q4	$0	Hold	45	–	–	﹤0.01%	2077
2019 Q3	$0	Buy	+45	New	+$437	﹤0.01%	2354
2019 Q2	–	Sell	-54	Closed	-$1K	–	2312
2019 Q1	$1K	Hold	54	–	–	﹤0.01%	2042
2018 Q4	$0	Buy	+54	New	+$620	﹤0.01%	2276

Other funds holding IRWD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Private Capital Group's IRWD Position: Q2 2022 in Review

Private Capital Group held its Ironwood Pharmaceuticals (IRWD) position steady in Q2 2022 at 45 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1724.

Private Capital Group first reported a position in IRWD in Q4 2018 and has held it in 14 quarters since. 239 funds tracked by Wall St. Rank hold IRWD as of Q2 2022.

Private Capital Group held 45 shares of Ironwood Pharmaceuticals worth $1K as of Q2 2022.
Private Capital Group left its Ironwood Pharmaceuticals share count unchanged in Q2 2022.
Ironwood Pharmaceuticals made up ﹤0.01% of Private Capital Group's portfolio in Q2 2022, its #1724 holding.
Private Capital Group first reported a position in Ironwood Pharmaceuticals in Q4 2018 and has held it in 14 quarters since.
239 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.